1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Molecular Diagnostics for Infectious Disease Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Molecular Diagnostics for Infectious Disease Market Regional Analysis
6.2 Middle East & Africa Molecular Diagnostics for Infectious Disease Market Revenue 2020-2030 (US$ Million)
6.3 Middle East & Africa Molecular Diagnostics for Infectious Disease Market Forecast Analysis
7. Middle East & Africa Molecular Diagnostics for Infectious Disease Market Analysis – by Type
7.1 Point-of-Care Testing and Laboratory Testing
- 7.1.1 Overview
- 7.1.2 Point-of-Care Testing and Laboratory Testing: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Middle East & Africa Molecular Diagnostics for Infectious Disease Market Analysis – by End User
8.1 Human Testing and Vet Testing
- 8.1.1 Overview
- 8.1.2 Human Testing and Vet Testing: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Middle East & Africa Molecular Diagnostics for Infectious Disease Market Analysis – by Application
9.1 Detection of Single Pathogen
- 9.1.1 Overview
- 9.1.2 Detection of Single Pathogen: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Detection of Two or More Pathogens
- 9.2.1 Overview
- 9.2.2 Detection of Two or More Pathogens: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Evaluation of Emerging Novel Infections
- 9.3.1 Overview
- 9.3.2 Evaluation of Emerging Novel Infections: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Surveillance and Early Detection of Biothreat Agents and Diseases-Related Biomarker
- 9.4.1 Overview
- 9.4.2 Surveillance and Early Detection of Biothreat Agents and Diseases-Related Biomarker: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.5 Antimicrobial Resistance Profiling
- 9.5.1 Overview
- 9.5.2 Antimicrobial Resistance Profiling: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.6 Patient stratification
- 9.6.1 Overview
- 9.6.2 Patient stratification: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.7 Drug Regimen Selection
- 9.7.1 Overview
- 9.7.2 Drug Regimen Selection: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.8 Toxicity Avoidance
- 9.8.1 Overview
- 9.8.2 Toxicity Avoidance: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.9 Therapeutic Monitoring
- 9.9.1 Overview
- 9.9.2 Therapeutic Monitoring: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.10 Detection of Predisposition to Disease
- 9.10.1 Overview
- 9.10.2 Detection of Predisposition to Disease: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Middle East & Africa Molecular Diagnostics for Infectious Disease Market Analysis – by Disease Type
10.1 Sepsis
- 10.1.1 Overview
- 10.1.2 Sepsis: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Prosthetic Joint Infection
- 10.2.1 Overview
- 10.2.2 Prosthetic Joint Infection: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.3 Endocarditis
- 10.3.1 Overview
- 10.3.2 Endocarditis: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.4 STDs
- 10.4.1 Overview
- 10.4.2 STDs: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.5 Mononucleosis
- 10.5.1 Overview
- 10.5.2 Mononucleosis: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.6 Group A Streptococcus
- 10.6.1 Overview
- 10.6.2 Group A Streptococcus: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.7 Sepsis
- 10.7.1 Overview
- 10.7.2 Sepsis: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.8 Prosthetic Joint Infection
- 10.8.1 Overview
- 10.8.2 Prosthetic Joint Infection: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.9 Endocarditis
- 10.9.1 Overview
- 10.9.2 Endocarditis: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.10 STDs
- 10.10.1 Overview
- 10.10.2 STDs: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.11 Chlamydia
- 10.11.1 Overview
- 10.11.2 Chlamydia: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.12 Gastrointestinal Infection
- 10.12.1 Overview
- 10.12.2 Gastrointestinal Infection: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.13 Tuberculosis
- 10.13.1 Overview
- 10.13.2 Tuberculosis: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.14 H1N1 Virus
- 10.14.1 Overview
- 10.14.2 H1N1 Virus: Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Middle East and Africa Analysis
11.1 Overview
11.2 Middle East and Africa
- 11.2.1 Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 11.2.1.1 Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 South Africa:
Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 South Africa: Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
- 11.2.1.1.2 South Africa: Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
- 11.2.1.1.3 South Africa: Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
- 11.2.1.1.4 South Africa: Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type
- 11.2.1.2 Saudi Arabia:
Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Saudi Arabia: Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
- 11.2.1.2.2 Saudi Arabia: Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
- 11.2.1.2.3 Saudi Arabia: Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
- 11.2.1.2.4 Saudi Arabia: Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type
- 11.2.1.3 UAE:
Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 UAE: Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
- 11.2.1.3.2 UAE: Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
- 11.2.1.3.3 UAE: Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
- 11.2.1.3.4 UAE: Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type
- 11.2.1.4 Rest of Middle East and Africa:
Middle East & Africa Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
- 11.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
- 11.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
- 11.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Abbott Laboratories
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Thermo Fisher Scientific Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 bioMerieux SA
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Danaher Corp
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Hologic Inc
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Siemens Healthineers AG
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Bruker Corp
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 DiaSorin SpA
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For Middle East & Africa Molecular Diagnostics for Infectious Disease Market
